Westlake Village BioPartners gathers $320 mln for maiden fund
Los Angeles-based Westlake Village BioPartners, a venture firm focused on life sciences, has raised $320 million for its debut fund. Dr. Beth Seidenberg, a general partner at Kleiner Perkins and former chief medical officer and head of global development at Amgen and Dr. Sean Harper, executive vice president and head of R&D at Amgen, will lead Westlake’s investing activities. And, Scott Ryles, chief operating officer at Kleiner Perkins, will be Westlake's chief operating officer.
5 September 2018•4 mins read
